Filing Details
- Accession Number:
- 0001209191-16-138022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-19 18:52:54
- Reporting Period:
- 2016-08-18
- Filing Date:
- 2016-08-19
- Accepted Time:
- 2016-08-19 18:52:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1305253 | Eiger Biopharmaceuticals Inc. | EIGR | Biological Products, (No Disgnostic Substances) (2836) | 361004130 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1488919 | P James Shaffer | 350 Cambridge Ave, Suite 350 Palo Alto CA 94306 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-18 | 3,125 | $15.70 | 5,620 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
